Cargando…

SARS-CoV-2 infection after alemtuzumab in a multiple sclerosis patient: milder disease symptoms in comparison with coinfected relatives: a case report and review of the literature

Literature data reporting SARS-CoV-2 infection in multiple sclerosis (MS) patients recently treated with immunodepleting agents as cladribine and alemtuzumab are very limited. The relationship between iatrogenic immunodeficiency and risk related to SARS-CoV-2 infection and its severe complications i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saraceno, Lorenzo, Susani, Emanuela Laura, Marazzi, Maria Raffaella, Moioli, Maria Cristina, Agostoni, Elio Clemente, Protti, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384460/ https://www.ncbi.nlm.nih.gov/pubmed/34431013 http://dx.doi.org/10.1007/s10072-021-05567-7

Ejemplares similares

Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
por: Habek, Mario
Publicado: (2021)

The claustrum sign in a parainfectious COVID-19 encephalitis
por: Laura Susani, Emanuela, et al.
Publicado: (2021)

Sleep disorders and mental health in hospital workers during the COVID-19 pandemic: a cross-sectional multicenter study in Northern Italy
por: Proserpio, Paola, et al.
Publicado: (2022)

Dengue–COVID-19 coinfection: the first reported case in the Philippines
por: Saipen, Angyap, et al.
Publicado: (2021)

An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID)
por: Ferrarese, Carlo, et al.
Publicado: (2020)

Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG): Case Report
por: Luciani, Michelangelo, et al.
Publicado: (2020)

Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design
por: Stowe, Julia, et al.
Publicado: (2021)

Coinfections in hospitalized COVID-19 patients are associated with high mortality: need for improved diagnostic tools
por: Kothadia, Sonya, et al.
Publicado: (2022)

Procalcitonin as marker for bacterial coinfection among adult COVID-19 patients in a tertiary-care hospital in the Philippines
por: Pesebre, Angelie Lorraine, et al.
Publicado: (2022)

Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide
por: Yetkin, Mehmet Fatih, et al.
Publicado: (2021)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study
por: Affinito, Giuseppina, et al.
Publicado: (2023)

Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge
por: D’Apolito, Maria, et al.
Publicado: (2023)

Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters
por: Arighi, Andrea, et al.
Publicado: (2021)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
por: Sadeghmousavi, Shaghayegh, et al.
Publicado: (2020)

The importance of early detection of ENT symptoms in mild-to-moderate COVID-19
por: Spinato, Giacomo, et al.
Publicado: (2021)

Impact of COVID-19 lockdown on progressive multiple sclerosis patients
por: Vercellino, Marco, et al.
Publicado: (2022)

Covid-19 epidemic in Italy: evolution, projections and impact of government measures
por: Sebastiani, Giovanni, et al.
Publicado: (2020)

Characteristics of Venous Thromboembolism in COVID-19 Patients: A Multicenter Experience from Northern Italy
por: Marone, Enrico M., et al.
Publicado: (2020)

Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
por: Devogelaere, Jens, et al.
Publicado: (2020)

Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19
por: De Marchi, Fabiola, et al.
Publicado: (2020)

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
por: Bonavita, Simona, et al.
Publicado: (2020)

Bilateral anterior ischemic optic neuropathy after COVID-vaccination
por: Iodice, Francesco, et al.
Publicado: (2023)

The impact of headache symptoms in a population of Italian university students during the COVID period: an observational study based on 4926 cases
por: Saracco, Maria Gabriella, et al.
Publicado: (2022)

Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail
por: Bombaci, Alessandro, et al.
Publicado: (2020)

Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID-19 era
por: Toscano, Simona, et al.
Publicado: (2022)

COVID-19 Symptoms Can Prolong Seasonal Flu Infection Symptoms and Recovery Times Among Obese African American Female Population
por: Asare, Smart, et al.
Publicado: (2021)

Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
por: Sparaco, Maddalena, et al.
Publicado: (2022)

A Symptom-Based Rule for Diagnosis of COVID-19
por: Smith, David S., et al.
Publicado: (2020)

COVID-19 and Pregnancy: Risk, Symptoms, Diagnosis, and Treatment
por: Hapshy, Vera, et al.
Publicado: (2021)

Optimizing COVID-19 Symptom Screening in the Pediatric Population
por: Zhou, Geena, et al.
Publicado: (2021)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021)

Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
por: Kuzu Kumcu, Müge, et al.
Publicado: (2022)

Impact of Gastrointestinal Symptoms in COVID-19: a Molecular Approach
por: Sonkar, Charu, et al.
Publicado: (2020)

Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19
por: Kacem, Imen, et al.
Publicado: (2020)

Symptoms and Clinical Outcomes of Coronavirus Disease 2019 in the Outpatient Setting
por: Knight, Dacre, et al.
Publicado: (2021)

Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study
por: Dalla Costa, Gloria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_db2c8s0h1gu146of9gmocfruoc